A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Rationale and Design of the AIM-POWER Trial

By sjmartinez • March 24, 2025

DeVore AD, Xie J, Etters L, Rael E, Wibowo S, Hao C, Majmudar M, Hernandez AF, Fonarow GC, Desai AS. A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Rationale and Design of the AIM-POWER Trial. J Card Fail. 2025 Mar 21:S1071-9164(25)00143-5. doi: 10.1016/j.cardfail.2025.02.018. Epub ahead of print. PMID: 40122512.

Tags: Cardiology/Epi, clinical trials, digital therapeutics, heart failure, Publications

Prototyping and Manufacturing of Customized Over-Encapsulated Polypills for Heart Failure with Reduced Ejection Fraction in a Safety-Net Healthcare System

DeJong C, Durstenfeld MS, Davis J, Wang CS, Chen J, Kazi DS, Hickey MD, Grochowski J, Steward WT, Riley ED, Zier LS, Moreau N, Huffman[...]

Comparative specialization of intrinsic cardiac neurons in humans, mice and pigs

Tompkins JD, Hoover DB, Havton LA, Patel JC, Cho Y, Smith EH, Biscola NP, Ajijola OA, Shivkumar K, Ardell JL. Comparative specialization of intrinsic cardiac[...]

Two-year Outcomes of Transcatheter Edge-to-edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Trial

Kar S, Makkar RR, Whisenant BK, Hamid N, Naik H, Tadros P, Price MJ, Singh G, Schwartz JG, Kapadia S, Alli O, Horr S, Seshiah[...]